SCNI
Scinai Immunotherapeutics
SCNI
SCNI
3 hedge funds and large institutions have $122K invested in Scinai Immunotherapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$3K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
| $63K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $56K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3K | +$3K | +8 | New |
|